
    
      This is a retrospective comparison of patients with LA-HNSCC treated with chemoradiotherapy
      at 2 tertiary care centers in the Netherlands (UMCG and VUmc), where one center routinely
      gives carboplatin plus 5FU (UMCG) and the other center (VUmc) uses high dose cisplatin as
      standard of care.
    
  